Impact of the severe acute respiratory syndrome coronavirus 2 pandemic on the incidence of type 1 diabetes mellitus in children in Yamanashi, Japan
Abstract It has been hypothesized that the biopsychosocial stress associated with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, in combination with the immunological effects of SARS-CoV-2 and pancreatic β-cell dysfunction, may contribute to the onset of type 1 diabetes (...
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-01-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-024-84654-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841559710206001152 |
|---|---|
| author | Tomohiro Saito Mie Mochizuki Kisho Kobayashi Hiromune Narusawa Daisuke Watanabe Koichi Makino Hideaki Yagasaki Kazumasa Sato Tomoaki Sano Masanori Ohta Hiroshi Yokomichi Shin Amemiya Koji Kobayashi |
| author_facet | Tomohiro Saito Mie Mochizuki Kisho Kobayashi Hiromune Narusawa Daisuke Watanabe Koichi Makino Hideaki Yagasaki Kazumasa Sato Tomoaki Sano Masanori Ohta Hiroshi Yokomichi Shin Amemiya Koji Kobayashi |
| author_sort | Tomohiro Saito |
| collection | DOAJ |
| description | Abstract It has been hypothesized that the biopsychosocial stress associated with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, in combination with the immunological effects of SARS-CoV-2 and pancreatic β-cell dysfunction, may contribute to the onset of type 1 diabetes (T1D) in children. In this study, we documented the incidences of T1D in Yamanashi Prefecture, Japan, from 1986 to 2018, and expanded the analysis to include cases from 2019 to 2022 to evaluate the potential influence of coronavirus disease 2019 (COVID-19) on T1D incidence. The COVID-19 pandemic period was defined as 2020 to 2022. Data spanning from 1986 to 2022 were analyzed in annual increments, while data from 1987 to 2022 were analyzed in 3-year interval increments using Joinpoint regression analysis. Across all analyses, no joinpoints were identified, and a consistent linear increase was observed. These findings suggest that there was no statistically significant change in the incidence of T1D attributable to the COVID-19 pandemic in Yamanashi Prefecture. The annual increase in the incidence was calculated to be 3.384% per year, while the increase in the 3-year interval incidence was calculated to be 2.395% per year. Although the incidence of pediatric T1D among children aged 0–14 years in Yamanashi Prefecture increased during the COVID-19 pandemic (2020–2022), this trend appeared to be a continuation of the pre-2019 increase. The direct or indirect impact of COVID-19 on this trend could not be conclusively determined due to the limited number of cases included in this study. |
| format | Article |
| id | doaj-art-0731ef1ecd7d48328882d4f5390927ee |
| institution | Kabale University |
| issn | 2045-2322 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj-art-0731ef1ecd7d48328882d4f5390927ee2025-01-05T12:14:11ZengNature PortfolioScientific Reports2045-23222025-01-0115111210.1038/s41598-024-84654-zImpact of the severe acute respiratory syndrome coronavirus 2 pandemic on the incidence of type 1 diabetes mellitus in children in Yamanashi, JapanTomohiro Saito0Mie Mochizuki1Kisho Kobayashi2Hiromune Narusawa3Daisuke Watanabe4Koichi Makino5Hideaki Yagasaki6Kazumasa Sato7Tomoaki Sano8Masanori Ohta9Hiroshi Yokomichi10Shin Amemiya11Koji Kobayashi12Department of Pediatrics, Faculty of Medicine Graduate School of Medicine, University of YamanashiDepartment of Pediatrics, Faculty of Medicine Graduate School of Medicine, University of YamanashiDepartment of Pediatrics, Faculty of Medicine Graduate School of Medicine, University of YamanashiDepartment of Pediatrics, Faculty of Medicine Graduate School of Medicine, University of YamanashiDepartment of Pediatrics, Faculty of Medicine Graduate School of Medicine, University of YamanashiDepartment of Pediatrics, Faculty of Medicine Graduate School of Medicine, University of YamanashiDepartment of Pediatrics, Faculty of Medicine Graduate School of Medicine, University of YamanashiDepartment of Pediatrics, Faculty of Medicine Graduate School of Medicine, University of YamanashiDepartment of Pediatrics, Faculty of Medicine Graduate School of Medicine, University of YamanashiDepartment of Pediatrics, Faculty of Medicine Graduate School of Medicine, University of YamanashiDepartment of Pediatrics, Faculty of Medicine Graduate School of Medicine, University of YamanashiDepartment of Pediatrics, Faculty of Medicine, Saitama Medical UniversityDepartment of Pediatrics, Faculty of Medicine Graduate School of Medicine, University of YamanashiAbstract It has been hypothesized that the biopsychosocial stress associated with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, in combination with the immunological effects of SARS-CoV-2 and pancreatic β-cell dysfunction, may contribute to the onset of type 1 diabetes (T1D) in children. In this study, we documented the incidences of T1D in Yamanashi Prefecture, Japan, from 1986 to 2018, and expanded the analysis to include cases from 2019 to 2022 to evaluate the potential influence of coronavirus disease 2019 (COVID-19) on T1D incidence. The COVID-19 pandemic period was defined as 2020 to 2022. Data spanning from 1986 to 2022 were analyzed in annual increments, while data from 1987 to 2022 were analyzed in 3-year interval increments using Joinpoint regression analysis. Across all analyses, no joinpoints were identified, and a consistent linear increase was observed. These findings suggest that there was no statistically significant change in the incidence of T1D attributable to the COVID-19 pandemic in Yamanashi Prefecture. The annual increase in the incidence was calculated to be 3.384% per year, while the increase in the 3-year interval incidence was calculated to be 2.395% per year. Although the incidence of pediatric T1D among children aged 0–14 years in Yamanashi Prefecture increased during the COVID-19 pandemic (2020–2022), this trend appeared to be a continuation of the pre-2019 increase. The direct or indirect impact of COVID-19 on this trend could not be conclusively determined due to the limited number of cases included in this study.https://doi.org/10.1038/s41598-024-84654-zType 1 diabetesCoronavirusCOVID-19SARS-CoV-2IncidencePandemic |
| spellingShingle | Tomohiro Saito Mie Mochizuki Kisho Kobayashi Hiromune Narusawa Daisuke Watanabe Koichi Makino Hideaki Yagasaki Kazumasa Sato Tomoaki Sano Masanori Ohta Hiroshi Yokomichi Shin Amemiya Koji Kobayashi Impact of the severe acute respiratory syndrome coronavirus 2 pandemic on the incidence of type 1 diabetes mellitus in children in Yamanashi, Japan Scientific Reports Type 1 diabetes Coronavirus COVID-19 SARS-CoV-2 Incidence Pandemic |
| title | Impact of the severe acute respiratory syndrome coronavirus 2 pandemic on the incidence of type 1 diabetes mellitus in children in Yamanashi, Japan |
| title_full | Impact of the severe acute respiratory syndrome coronavirus 2 pandemic on the incidence of type 1 diabetes mellitus in children in Yamanashi, Japan |
| title_fullStr | Impact of the severe acute respiratory syndrome coronavirus 2 pandemic on the incidence of type 1 diabetes mellitus in children in Yamanashi, Japan |
| title_full_unstemmed | Impact of the severe acute respiratory syndrome coronavirus 2 pandemic on the incidence of type 1 diabetes mellitus in children in Yamanashi, Japan |
| title_short | Impact of the severe acute respiratory syndrome coronavirus 2 pandemic on the incidence of type 1 diabetes mellitus in children in Yamanashi, Japan |
| title_sort | impact of the severe acute respiratory syndrome coronavirus 2 pandemic on the incidence of type 1 diabetes mellitus in children in yamanashi japan |
| topic | Type 1 diabetes Coronavirus COVID-19 SARS-CoV-2 Incidence Pandemic |
| url | https://doi.org/10.1038/s41598-024-84654-z |
| work_keys_str_mv | AT tomohirosaito impactofthesevereacuterespiratorysyndromecoronavirus2pandemicontheincidenceoftype1diabetesmellitusinchildreninyamanashijapan AT miemochizuki impactofthesevereacuterespiratorysyndromecoronavirus2pandemicontheincidenceoftype1diabetesmellitusinchildreninyamanashijapan AT kishokobayashi impactofthesevereacuterespiratorysyndromecoronavirus2pandemicontheincidenceoftype1diabetesmellitusinchildreninyamanashijapan AT hiromunenarusawa impactofthesevereacuterespiratorysyndromecoronavirus2pandemicontheincidenceoftype1diabetesmellitusinchildreninyamanashijapan AT daisukewatanabe impactofthesevereacuterespiratorysyndromecoronavirus2pandemicontheincidenceoftype1diabetesmellitusinchildreninyamanashijapan AT koichimakino impactofthesevereacuterespiratorysyndromecoronavirus2pandemicontheincidenceoftype1diabetesmellitusinchildreninyamanashijapan AT hideakiyagasaki impactofthesevereacuterespiratorysyndromecoronavirus2pandemicontheincidenceoftype1diabetesmellitusinchildreninyamanashijapan AT kazumasasato impactofthesevereacuterespiratorysyndromecoronavirus2pandemicontheincidenceoftype1diabetesmellitusinchildreninyamanashijapan AT tomoakisano impactofthesevereacuterespiratorysyndromecoronavirus2pandemicontheincidenceoftype1diabetesmellitusinchildreninyamanashijapan AT masanoriohta impactofthesevereacuterespiratorysyndromecoronavirus2pandemicontheincidenceoftype1diabetesmellitusinchildreninyamanashijapan AT hiroshiyokomichi impactofthesevereacuterespiratorysyndromecoronavirus2pandemicontheincidenceoftype1diabetesmellitusinchildreninyamanashijapan AT shinamemiya impactofthesevereacuterespiratorysyndromecoronavirus2pandemicontheincidenceoftype1diabetesmellitusinchildreninyamanashijapan AT kojikobayashi impactofthesevereacuterespiratorysyndromecoronavirus2pandemicontheincidenceoftype1diabetesmellitusinchildreninyamanashijapan |